Kelly Thomas Patrick
Xenon Pharmaceuticals Inc · NASDAQ
+15,000 sh · $559.7K
BlackRock
13F filer
$81.7M
2,095,894 sh
Two Sigma Investments
13F filer
$35.2M
606,085 sh
Renaissance Technologies
13F filer
$17.5M
300,500 sh
Duquesne Family Office
13F filer
$14.4M
238,600 sh
Mortimer Ian
US insider
$1.1M
30,000 sh
Kelly Thomas Patrick
US insider
$559.7K
15,000 sh
Svoronos Dawn
US insider
$41.9K
5,144 sh
Kelly Thomas Patrick
Xenon Pharmaceuticals Inc · NASDAQ
+15,000 sh · $559.7K
Mortimer Ian
Xenon Pharmaceuticals Inc · NASDAQ
+30,000 sh · $1.1M
Svoronos Dawn
Xenon Pharmaceuticals Inc · NASDAQ
+5,144 sh · $41.9K
Kenney Christopher John
Xenon Pharmaceuticals Inc · NASDAQ
−6,368 sh · $383.1K
Kenney Christopher John
Xenon Pharmaceuticals Inc · NASDAQ
−700 sh · $42.7K
Duquesne Family Office
Xenon Pharmaceuticals Inc · NASDAQ
238,600 sh · $14.4M
Duquesne Family Office
Xenon Pharmaceuticals Inc · NASDAQ
238,600 sh · $13.9M
Renaissance Technologies
Xenon Pharmaceuticals Inc · NASDAQ
300,500 sh · $17.5M
Two Sigma Investments
Xenon Pharmaceuticals Inc · NASDAQ
606,085 sh · $35.2M
BlackRock
Xenon Pharmaceuticals Inc · NASDAQ
2,095,894 sh · $81.7M